KR20160130780A - Methods for diagnosing and treating inflammatory

Official gazette of the unexamined patents

KR20160130780A - Methods for diagnosing and treating inflammatory bowel disease - Google Patents

KR20160130780A - Methods for diagnosing and treating inflammatory bowel disease - Google Patents

The role of biomarkers for the management of ulcerative colitis - American Gastroenterological Association

Biomarkers of ulcerative colitis disease activity CXCL1, CYP2R1, LPCAT1, and NEU4 and their relationship to immune infiltrates

Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression

Frontiers Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial - The Lancet

Treat‐to‐target and sequencing therapies in Crohn's disease - Garcia - 2022 - United European Gastroenterology Journal - Wiley Online Library

Recent advances in inflammatory bowel disease therapy - ScienceDirect